AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7539609
Drug: Half-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-dose aprotinin
Trial: 8198266
Drug: Propofol 10
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 10 mg intravenously (i.v.)
Trial: 29909435
Drug: Active PBMt
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active PBMt (Photobiomodulation therapy)
Trial: 26362286
Drug: Resveratrol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol treatment
Trial: 19819469
Drug: 25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/kg of MgSO(4)
Trial: 19819469
Drug: 50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/kg of MgSO(4)
Trial: 12453969
Drug: Iron depletion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron depletion (three extractions of 500 ml blood at 2-week intervals; group 1A)
Trial: 7555551
Drug: Acarbose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (50 to 300 mg three times daily)
Trial: 12712782
Drug: Alfentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil infusion
Trial: 11800047
Drug: Diphenhydramine (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (placebo control) infusion
Trial: 9479922
Drug: Monitored chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monitored chlorhexidine (CHX) gel treatment (3 x 5 min 1% CHX gel, monitored over 12 weeks)
Trial: 9479922
Drug: Conventional two-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional two-day CHX treatment (3 x 5 min 1% CHX gel on two consecutive days)
Trial: 2537095
Drug: enalapril (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (10-20 mg/day)
Trial: 242030
Drug: Neoston (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoston (2 g, taken as two times two pills orally 2 and 5 hrs before tests)
Trial: 242030
Drug: Neoston (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoston (2 g)
Trial: 31218713
Drug: Topical glucocorticoids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glucocorticoids (mometasone furoate, 100 µg in each nostril once daily) and saline irrigation (150 mL twice a day) for 2 weeks
Trial: 31218713
Drug: Inhalation aerosol
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation aerosol therapy composed of essential oils, saline, glucocorticoids, and antibiotics, once daily 5 times per week for 2 weeks
Trial: 25074688
Drug: Fostamatinib 100
RxNorm normalized name: fostamatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fostamatinib 100 mg twice daily for 24 weeks plus placebo injection every 2 weeks (Arm A)
Trial: 25074688
Drug: Fostamatinib 100
RxNorm normalized name: fostamatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fostamatinib 100 mg twice daily for 4 weeks, then 150 mg once daily up to Week 24 plus placebo injection every 2 weeks (Arm B)
Trial: 25074688
Drug: Fostamatinib 100
RxNorm normalized name: fostamatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fostamatinib 100 mg twice daily for 4 weeks, then 100 mg once daily up to Week 24 plus placebo injection every 2 weeks (Arm C)
Trial: 25074688
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg every 2 weeks for 24 weeks plus oral placebo twice daily (Arm D)
Trial: 25074688
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo twice daily for 6 weeks, plus placebo injection every 2 weeks, then a switch to arm A or B (Arm E)
Trial: 21450019
Drug: SNB after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SNB after primary chemotherapy
Trial: 18640474
Drug: Levalbuterol 1.25
RxNorm normalized name: levalbuterol 1.25 mg/3 mL inhalation solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levalbuterol 1.25 mg q6-8h
Trial: 18640474
Drug: Racemic albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic albuterol 2.5 mg q1-4h
Trial: 12737671
Drug: Combined low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined low-dose oral contraceptives (specific types not detailed)
Trial: 10709162
Drug: 201 mg
RxNorm normalized name: ubidecarenone/vit E acet 100 mg-201 mg ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 201 mg fenofibrate + 40 mg pravastatin
Trial: 10709162
Drug: 201 mg
RxNorm normalized name: ubidecarenone/vit E acet 100 mg-201 mg ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 201 mg fenofibrate alone
Trial: 10709162
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg pravastatin alone
Trial: 9360431
Drug: Single-dose ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose ceftriaxone (2 g intravenous prior to surgery)
Trial: 9360431
Drug: Multiple-dose cefuroxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose cefuroxime (1.5 g intravenous prior to surgery and 750 mg intramuscular every 8 hours for 48 hours)
Trial: 31365624
Drug: Fructose (75g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructose (75g dissolved in 200 mL of mineral water)
Trial: 31365624
Drug: Glucose (75g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (75g dissolved in 200 mL of mineral water)
Trial: 25453517
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine formula (HMG)
Trial: 25453517
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine formula combined with lactulose (HMCLG)
Trial: 11871742
Drug: Low-fat content
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat content nutrient formula (ED group) with 3.4 g of fat per 2000-kcal dose
Trial: 11871742
Drug: High amount
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High amount of medium-chain triglycerides nutrient formula (TL group) with 55.6 g of fat per 2000-kcal dose
Trial: 11092663
Drug: Levosimendan (10‐min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan (10‐min intravenous bolus of 3, 6, 12, 24 or 36 microg/kg, followed by a 24‐h infusion of 0.05, 0.1, 0.2, 0.4 or 0.6 microg/kg/min)
Trial: 11092663
Drug: Dobutamine (open‐label
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine (open‐label infusion of 6 microg/kg/min)
Trial: 8810934
Drug: Dalteparin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (200 IU kg‐1) given as a once‐daily subcutaneous injection
Trial: 8810934
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) aPTT adjusted i.v. infusion for 6 to 10 days
Trial: 1412723
Drug: OKT3 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OKT3 (5 mg/day) for the first 14 postoperative days
Trial: 4096744
Drug: Ticlopidine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (750 mg/d)
Trial: 30948756
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg L-DOPA
Trial: 26584888
Drug: MultiGeneAngio (MGA)
RxNorm normalized name: MGA
DrugBank: Megestrol acetate (DB00351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MultiGeneAngio (MGA) - a single intra-arterial infusion of transduced autologous venous smooth muscle cells expressing VEGF165 and endothelial cells expressing Ang-1 (Cohort 1: 1 × 10^7, Cohort 2: 2 × 10^7, Cohort 3: 5 × 10^7, Cohort 4: 7 × 10^7)
Trial: 22434783
Drug: Twice-weekly, school-based,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly, school-based, 10-min jumping regime
Trial: 22434783
Drug: Twice-weekly, school-based,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly, school-based, 10-min jumping regime (boys)
Trial: 25466242
Drug: Eplerenone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone (50 mg/day)
Trial: 15616239
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 1,000 mg/day t.i.d.
Trial: 15616239
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 500 mg/day t.i.d.
Trial: 12579174
Drug: Suction group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suction group (n = 80) received 4 L min(‐1) O(2) with nasal cannula and expired air was aspired with a Y‐piece suction system
Trial: 12579174
Drug: Non-suction group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-suction group (n = 80) received 4 L min(‐1) O(2) with nasal cannula
Trial: 10687256
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg daily for 2 years)
Trial: 22784842
Drug: Salsalate (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (3 g daily)
Trial: 19404692
Drug: 10‐mg sustained‐release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mg sustained‐release clotrimazole varnish
Trial: 19404692
Drug: 10‐mg clotrimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mg clotrimazole oral troche
Trial: 18225447
Drug: CB1 antagonists;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CB1 antagonists; specific dosage and duration not available
Trial: 12038874
Drug: Short- and
RxNorm normalized name: ALLERGENIC EXTRACT,RAGWEED,SHORT AND TALL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short- and long-term inhaled bronchodilators
Trial: 12038874
Drug: Theophyllines (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophyllines (intravenous and oral)
Trial: 22116799
Drug: Macrolide antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macrolide antibiotics
Trial: 12038874
Drug: Intravenous immunoglobulin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin, cyclosporine, leukotriene antagonists
Trial: 9794853
Drug: Drug interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug interventions
Trial: 8904473
Drug: IVIG 800
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 800 mg/kg/day for 3 days plus phototherapy
Trial: 31046493
Drug: Medicinal plants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicinal plants used in the treatment of kidney stones
Trial: 25431430
Drug: Mindfulness-based group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based group therapy
Trial: 28438147
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (mostly cognitive-based therapy)
Trial: 25555830
Drug: Individualized complementary
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized complementary medicine (CM group)
Trial: 24303433
Drug: 4ml of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4ml of solution containing 1:200000 adrenaline and 2mg/kg tramadol injected in peritonsillar space (Group A)
Trial: 21716117
Drug: Prophylactic analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic analgesia with sublingual tramadol Hcl (50 mg) and oral lorazepam (1 mg)
Trial: 21716117
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam (5 mg) alone
Trial: 19247187
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg pretreatment
Trial: 19247187
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg pretreatment with statin therapy
Trial: 19247187
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg pretreatment in patients with diabetes
Trial: 19247187
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg pretreatment in tobacco smokers
Trial: 10694560
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (PeCT) - fluorouracil, doxorubicin, and cyclophosphamide
Trial: 3005801
Drug: Cortisol administration
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol administration after a midnight dose of metyrapone (30 mg/kg)
Trial: 31870463
Drug: EMIQ® (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMIQ® (2 mg aglycone equivalent)/kg body weight
Trial: 22269076
Drug: Self-administered stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered stress management training (SSMT)
Trial: 20028830
Drug: Partial Reinforcement
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial Reinforcement (full dose 25% to 50% of the time, placebo other times)
Trial: 20028830
Drug: Dose Control
RxNorm normalized name: Assure Dose Control Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose Control (continuous reinforcement with 25% to 50% of the initial dose)
Trial: 20028830
Drug: Standard Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Therapy (active drug every treatment with 100% of the initial dose)
Trial: 20028830
Drug: Dose Control
RxNorm normalized name: Assure Dose Control Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose Control
Trial: 20028830
Drug: Standard Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Therapy
Trial: 18400458
Drug: Internal ports
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal ports with topical anesthetic
Trial: 16258594
Drug: Physiological saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline 5 ml (Group A)
Trial: 16258594
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 microg/kg + dexamethasone 8 mg (Group B)
Trial: 16258594
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 microg/kg + droperidol 1.25 mg (Group C)
Trial: 16258594
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg (Group D)
Trial: 7781632
Drug: Continuous spinal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous spinal anaesthesia (38.4 mg hyperbaric lignocaine 5%)
Trial: 7781632
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anaesthesia (10.8 mg hyperbaric bupivacaine 0.5%)
Trial: 7781632
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anaesthesia
Trial: 6998536
Drug: Carbohydrate infusion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate infusion at 0.025 MJ (6 kcal) per kg body weight per 24 h
Trial: 6998536
Drug: Carbohydrate infusion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate infusion at 0.105 MJ (25 kcal) per kg body weight per 24 h
Trial: 6998536
Drug: Carbohydrate infusion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate infusion at 0.167 MJ (40 kcal) per kg body weight per 24 h
Trial: 24765899
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (ITM) 0.2 mg
Trial: 9311220
Drug: Control (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (2 ml of 0.9% saline)
Trial: 29355292
Drug: Ultrasound-guided corticosteroid
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided corticosteroid injection (1 ml Betamethasone)
Trial: 29355292
Drug: Direct approach
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct approach corticosteroid injection (1 ml Betamethasone)
Trial: 28129555
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (CBT) or acceptance and commitment therapy (ACT) for 12 weeks
Trial: 23398459
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate 0.1% ointment applied twice weekly
Trial: 23398459
Drug: Topical vitamin
RxNorm normalized name: vitamin A Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vitamin E applied once daily
Trial: 23398459
Drug: Cold cream
RxNorm normalized name: cold cream
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold cream applied once daily
Trial: 23578980
Drug: Indacaterol 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 300 μg once-daily
Trial: 18653310
Drug: Group cognitive
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive behavior therapy (CBT)
Trial: 16551272
Drug: Flavanol-rich chocolate
RxNorm normalized name: RESOURCE INSTANT CRYSTALS (RICH CHOCOLATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavanol-rich chocolate bar and cocoa beverage daily (total flavanols, 444 mg/day)
Trial: 16551272
Drug: Matching isocaloric
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching isocaloric placebos daily (total flavanols, 19.6 mg/day)
Trial: 12939717
Drug: Rituximab (given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (given weekly as a single agent)
Trial: 12939717
Drug: Rituximab (thrice-weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (thrice-weekly dosing schedule)
Trial: 12939717
Drug: Rituximab concurrent
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab concurrent with fludarabine
Trial: 12939717
Drug: Rituximab with
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab with appropriate premedication and a stepped up dosing schedule
Trial: 10940817
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream A (dissolved)
Trial: 10940817
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream B (dispersed)
Trial: 9221629
Drug: Regional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional treatment (portal vein or intraperitoneal) combined with systemic chemotherapy
Trial: 9221629
Drug: Immunotherapy (autologous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (autologous tumor cell-BCG or monoclonal antibody treatment)
Trial: 6299652
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg daily
Trial: 3307550
Drug: Ketamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2 mg/kg)
Trial: 29388288
Drug: Dexmedetomidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (2 μg/kg)
Trial: 29388288
Drug: Control (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (40 mL of 0.25% bupivacaine)
Trial: 1441863
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus adrenaline 75 mg + 150 micrograms
Trial: 1441863
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus adrenaline 50 mg + 100 micrograms
Trial: 1441863
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus adrenaline 25 mg + 50 micrograms
Trial: 1441863
Drug: Postoperative analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesics administration
Trial: 21318060
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine injection at bedtime (21:00-24:00)
Trial: 21318060
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine injection at breakfast (06:00-09:00)
Trial: 10592547
Drug: Medication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication treatment (TM)
Trial: 10592547
Drug: Not treated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not treated with medication
Trial: 8947980
Drug: Intranasal metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal metoclopramide 20 mg
Trial: 2567792
Drug: Very low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Very low-dose aspirin plus dipyridamole